Follow The Filings

GRMN Garmin Ltd.

Consumer Discretionary, filed as Garmin Ltd (COMMON STOCK), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $57K

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.03%

Who owns GRMN

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.03% Hold 200 $57K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GRMN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GRMN insider trades
  • None no insider bought on the open market
  • $7.1M sold by 8 insiders outside a trading plan
  • $12.8M sold by 3 insiders under 10b5-1 plans
  1. Cheng-Wei Wang General Manager - Garmin Corp.
    Sale
    $3M 9,941 shares at $299.36 25% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  2. Sean Biddlecombe Managing Director, EMEA
    Sale
    $289K 986 shares at $292.88 14% of stake
    Traded Jul 31 Filed Jul 31
    ↗
  3. Joshua H Maxfield VP, General Counsel
    Sale
    $335K 1,152 shares at $291.13 7.1% of stake
    Traded Jul 31 Filed Jul 31
    ↗
  4. Clifton A Pemble CEO
    Planned sale
    $1.2M 4,029 shares at $300.00 3.2% of stake
    Traded Jul 29 Filed Jul 31
    ↗
  5. Joseph J Hartnett Director
    Sale
    $152K 643 shares at $236.09 2.9% of stake
    Traded Jun 9 Filed Jun 9
    ↗
  6. Douglas G. Boessen CFO
    Planned sale
    $476K 2,000 shares at $237.91 7.1% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  7. Laurie A Minard VP, Human Resources
    Sale
    $262K 1,084 shares at $242.03 22% of stake
    Traded May 8 Filed May 8
    ↗
  8. Edward J. Link VP, Information Technology
    Sale
    $311K 1,275 shares at $243.64 4.3% of stake
    Traded Mar 10 Filed Mar 10
    ↗
  9. Clifton A Pemble CEO
    Planned sale
    $5M 19,914 shares at $251.58 14% of stake
    Traded Feb 26 Filed Feb 27
    ↗
  10. Matthew Munn EVP, Man. Director - Auto OEM
    Sale
    $1.3M 5,275 shares at $250.97 35% of stake
    Traded Feb 26 Filed Feb 27
    ↗
  11. Douglas G. Boessen CFO
    Planned sale
    $878K 3,487 shares at $251.66 11% of stake
    Traded Feb 26 Filed Feb 27
    ↗
  12. Patrick Desbois COO
    Planned sale
    $1.7M 6,694 shares at $251.65 10% of stake
    Traded Feb 26 Filed Feb 27
    ↗
  13. Susan Lyman VP, Consumer Sales & Marketing
    Sale
    $956K 3,805 shares at $251.32 34% of stake
    Traded Feb 26 Filed Feb 27
    ↗
  14. Laurie A Minard VP, Human Resources
    Sale
    $207K 837 shares at $247.28 13% of stake
    Traded Feb 23 Filed Feb 23
    ↗
  15. Sean Biddlecombe Managing Director, EMEA
    Sale
    $258K 1,071 shares at $240.76 12% of stake
    Traded Feb 20 Filed Feb 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 93 gifts, 28 stock grants, and 26 share withholdings for taxes.

Congress

2 members of Congress traded GRMN in the last three years: 3 buys and 1 sale. 4 members listed it in 2025 annual reports.

All Congress trades
  1. Kathy E. Manning D-NC-6Spouse Buy $1K–$15K Jul 2, 2024 filed Aug 16, 2024
  2. Kathy E. Manning D-NC-6Spouse Buy $1K–$15K Jul 2, 2024 filed Aug 16, 2024
  3. Kathy E. Manning D-NC-6Spouse Buy $50K–$100K Jul 2, 2024 filed Aug 16, 2024
  4. Tommy Tuberville R-ALJoint Sell $1K–$15K May 3, 2024 filed Jun 14, 2024

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $5.23B $6.3B $7.25B
Gross profit $3B $3.7B $4.26B
Gross margin * 57.5% 58.7% 58.7%
Net income $1.29B $1.41B $1.66B
Net margin * 24.7% 22.4% 23.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.46B $5.34B $6.25B
Total non-current assets * $4.14B $4.29B $4.75B
Total assets $8.6B $9.63B $10.99B
Total current liabilities $1.31B $1.51B $1.72B
Total equity $7.01B $7.85B $8.97B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.38B $1.43B $1.63B
Cash from investing -$332.97M -$393.33M -$645.24M
Cash from financing -$636.51M -$626.86M -$844.08M
Net change in cash $414.24M $386M $199.21M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.